Skip to content
Adrienne Monson – Lifestyle
Author:
Dianthus Therapeutics, Inc.
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
March 8, 2026
←
Previous Page
1
2